We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App





Intelligent Lung Ultrasound Provides Crucial Support for COVID-19 Testing Within Minutes

By HospiMedica International staff writers
Posted on 03 Jun 2021
Print article
Image: Column 1 and 2 show lung ultrasounds without and with annotated COVID-19 biomarkers (orange: moderate, red: severe). Columns 3 and 4 respectively show the semantic segmentations and contours of COVID-19 markers by means of deep learning analysis (Photo courtesy of Eindhoven University of Technology)
Image: Column 1 and 2 show lung ultrasounds without and with annotated COVID-19 biomarkers (orange: moderate, red: severe). Columns 3 and 4 respectively show the semantic segmentations and contours of COVID-19 markers by means of deep learning analysis (Photo courtesy of Eindhoven University of Technology)
Using fairly simple ultrasound machines that are enhanced with artificial intelligence (AI) could make it possible to establish whether a patient is suffering from severe lung disease, possibly COVID-19, within a few minutes.

A research team at Eindhoven University of Technology (Eindhoven, Netherlands) and the University of Trento (Trento, Italy) has been able to translate the expertise of top lung specialists into a software update for these ultrasound machines. This enables relative laymen to interpret the images in a manageable and comparatively inexpensive manner, just like the world’s best lung experts. The solution also offers various advantages over alternative imaging technologies such as CT or MRI: there are many more machines available (including in developing countries and rural areas), these are portable and manageable, do not use radioactive radiation (as with CT), have a minimal risk of contamination through the use of a cover around the sensor, and are comparatively cheap.

Additionally, these image analyses support a diagnosis that ultimately has to be made by the doctor. Further research is needed to determine with absolute certainty whether the lung deficiency is caused by COVID-19 or another lung disease such as severe pneumonia. In addition, more research is needed to be able to perform the complete diagnosis using this intelligent lung ultrasound system. The new technology will be offered to hospitals and the software update could eventually be installed directly on ultrasound machines, so that doctors have everything at their disposal, in real-time.

“With artificial intelligence, the most important biomarkers of severe lung diseases such as COVID-19 can be accurately determined on a lung ultrasound that visualizes the abnormalities at the edge of the lung and the changes in the structure of the network of pulmonary alveoli and interstitial tissue,” said Ruud van Sloun, Assistant Professor and researcher at Eindhoven University of Technology. “And because it’s a program which learns, it becomes even smarter with each new use, allowing it to even more accurately determine whether or not the patient may have COVID-19. We’re very optimistic regarding its quick application in hospitals and emergency rooms.”

Related Links:
Eindhoven University of Technology
University of Trento


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bronchoscope
EB-500

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.